Researchers launch study to unravel mysteries of rare nerve disorder

NCT ID NCT03918421

Recruiting now Knowledge-focused Sponsor: Hospices Civils de Lyon Source: ClinicalTrials.gov ↗

First seen Jan 25, 2026 · Last updated May 23, 2026 · Updated 17 times

Summary

This study aims to learn more about a rare nerve condition called IgM-anti-MAG peripheral neuropathy, which causes numbness and weakness. Researchers will collect detailed information from 45 patients to identify different types of the disease and how they respond to treatment. The goal is to create a better way to measure disability in these patients, which could improve future care.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for IMMUNOGLOBIN M ANTI-MYELIN-ASSOCIATED-GLYCOPROTEIN PERIPHERAL NEUROPATHY are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Centre de référence NNERf
RECRUITING

Le Kremlin-Bicêtre, 94275, France

Contact Email: •••••@•••••

Contact
Hospices Civils de Lyon Service Neurologie C, Pathologies Neuromusculaires, Unité 302
RECRUITING

Bron, 69500, France

Contact

Contact

Conditions

Explore the condition pages connected to this study.

IMMUNOGLOBIN M ANTI-MYELIN-ASSOCIATED-GLYCOPROTEIN PERIPHERAL NEUROPATHY